Korro Bio, Inc., a biopharmaceutical company, engages in the discovering, developing, and commercializing of genetic medicines based on editing RNA for the treatment of rare and highly prevalent diseases in the United States. The company's ...
Leadership
Ram Aiyar MBA, Ph.D.
CEO, President, Interim CFO, Principal Financial Officer & Director
Loic Vincent Ph.D.
Chief Scientific Officer
Jeffrey M. Cerio J.D., Pharm.D.
Senior VP, General Counsel & Corporate Secretary
Andrew Fraley Ph.D.Founder
Co-Founder & Advisor
Joshua Rosenthal Ph.D.Founder
Co-Founder & Advisor
Todd Chappell M.B.A.
Chief Operating Officer
Oliver Dolan
Senior VP of Finance & Principal Accounting Officer
Stephanie Engels
Chief People Officer
Gaozhong Zhu Ph.D.
SVP of Chemistry, Manufacturing and Controls & Technical Operations
